Long non-coding RNAs in prostate cancer: biological and clinical implications
Date
2019
Authors
Das, R.
Feng, F.Y.
Selth, L.A.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Molecular and Cellular Endocrinology, 2019; 480:142-152
Statement of Responsibility
Rajdeep Das, Felix Y. Feng, Luke A. Selth
Conference Name
Abstract
Prostate cancer (PCa) is a major health issue in the Western world. Current clinical imperatives for this disease include better stratification of indolent versus aggressive disease to enable improved patient management, as well as the identification of more effective therapies for the prevention and treatment of metastatic and therapy-resistant PCa. The advent of next-generation transcriptomics led to the identification of an important class of molecules, long non-coding RNAs (lncRNAs). LncRNAs have critical functions in normal physiology, but their dysregulation has also been implicated in the development and progression of a variety of cancers, including PCa. Importantly, a subset of lncRNAs are highly prostate-specific, suggesting potential for utility as both biomarkers and therapeutic targets. In this review, we summarise the biology of lncRNAs and their mechanisms of action in the development and progression of prostate cancer. Additionally, we cast a critical eye over the potential for this class of molecules to impact on clinical practice.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2018 Elsevier B.V. All rights reserved.